{
  "id": "551910fa622b19434500000b",
  "type": "yesno",
  "question": "Is PLK2 involved in alpha-synuclein phosphorylation in Parkinson disease?",
  "ideal_answer": "PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assayThese results indicate that PLK2 plays a critical role in alpha-synuclein phosphorylation in central nervous system.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23983262",
    "http://www.ncbi.nlm.nih.gov/pubmed/21050448",
    "http://www.ncbi.nlm.nih.gov/pubmed/19004816"
  ],
  "snippets": [
    {
      "text": "An increase in \u03b1-synuclein levels due to gene duplications/triplications or impaired degradation is sufficient to trigger its aggregation and cause familial Parkinson disease ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23983262",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here, we report that Polo-like kinase 2 (PLK2), an enzyme up-regulated in synucleinopathy-diseased brains, interacts with, phosphorylates and enhances \u03b1-synuclein autophagic degradation in a kinase activity-dependent manner.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23983262",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Polo-like kinase 2 regulates selective autophagic \u03b1-synuclein clearance and suppresses its toxicity in vivo",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23983262",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Collectively, our findings demonstrate that PLK2 is a previously undescribed regulator of \u03b1-synuclein turnover and that modulating its kinase activity could be a viable target for the treatment of synucleinopathies.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23983262",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " \u03b1-Synuclein increased PLK2 levels and GSK-3\u03b2 activity and increased the levels of phosphorylated \u03b1-Synuclein and Tau",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21050448",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Several neurological diseases, including Parkinson disease and dementia with Lewy bodies, are characterized by the accumulation of alpha-synuclein phosphorylated at Ser-129 (p-Ser-129)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we submit evidence that polo-like kinase 2 (PLK2, also known as serum-inducible kinase or SNK) is a principle contributor to alpha-synuclein phosphorylation at Ser-129 in neurons.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PLK2 directly phosphorylates alpha-synuclein at Ser-129 in an in vitro biochemical assay",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These results indicate that PLK2 plays a critical role in alpha-synuclein phosphorylation in central nervous system.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19004816",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}